|
Market Closed -
NYSE
21:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.400 USD | +6.87% |
|
+35.92% | +2.94% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ATNM | Delayed | |
CBOE
| ATNM | Real-time | |
|
Tradegate
| 7AY1 | Real-time | |
|
Boerse Muenchen
| 7AY1 | Real-time | |
|
Deutsche Boerse AG
| 7AY1 | Delayed | |
|
Börse Stuttgart
| 7AY1 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 1.52 | 1.52 | 1.69 |
| Spread/Res. | -7.89% | -7.89% | -17.16% |
| Spread/Supp. | +40.63% | +86.99% | +75.57% |
| Support | 0.9955 | 0.7487 | 0.7974 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ATNM Stock
- Charts Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
